[go: up one dir, main page]

FR3031675B1 - COSMETIC OR PHARMACEUTICAL TREATMENT PROCESS WITHOUT THERAPEUTIC AIMS INTENDED TO DEVELOP THE BUST WHILE PROTECTING IT - Google Patents

COSMETIC OR PHARMACEUTICAL TREATMENT PROCESS WITHOUT THERAPEUTIC AIMS INTENDED TO DEVELOP THE BUST WHILE PROTECTING IT Download PDF

Info

Publication number
FR3031675B1
FR3031675B1 FR1500095A FR1500095A FR3031675B1 FR 3031675 B1 FR3031675 B1 FR 3031675B1 FR 1500095 A FR1500095 A FR 1500095A FR 1500095 A FR1500095 A FR 1500095A FR 3031675 B1 FR3031675 B1 FR 3031675B1
Authority
FR
France
Prior art keywords
bust
cosmetic
protecting
develop
treatment process
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR1500095A
Other languages
French (fr)
Other versions
FR3031675A1 (en
Inventor
Etienne Soudant
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to FR1500095A priority Critical patent/FR3031675B1/en
Publication of FR3031675A1 publication Critical patent/FR3031675A1/en
Application granted granted Critical
Publication of FR3031675B1 publication Critical patent/FR3031675B1/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/606—Nucleosides; Nucleotides; Nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A61K31/37—Coumarins, e.g. psoralen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/232—Angelica
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258—Panax (ginseng)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/577—Malvaceae (Mallow family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/577—Malvaceae (Mallow family)
    • A61K36/5775—Hibiscus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Birds (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Cosmetics (AREA)

Abstract

Procédé de traitement cosmétique ou pharmaceutique sans visée thérapeutique destiné à développer le buste tout en le protégeant du risque tumoral caractérisé en ce qu'il comprend au moins un extrait végétal capable à la fois d'inhiber l'expression des sirtuines et à la fois le repulper associé à au moins une substance capable de stimuler les récepteurs à l'adénosine.Cosmetic or pharmaceutical treatment process without therapeutic aim intended to develop the bust while protecting it from the risk of tumors, characterized in that it comprises at least one plant extract capable of both inhibiting the expression of sirtuins and at the same time the plump associated with at least one substance capable of stimulating adenosine receptors.

FR1500095A 2015-01-19 2015-01-19 COSMETIC OR PHARMACEUTICAL TREATMENT PROCESS WITHOUT THERAPEUTIC AIMS INTENDED TO DEVELOP THE BUST WHILE PROTECTING IT Expired - Fee Related FR3031675B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR1500095A FR3031675B1 (en) 2015-01-19 2015-01-19 COSMETIC OR PHARMACEUTICAL TREATMENT PROCESS WITHOUT THERAPEUTIC AIMS INTENDED TO DEVELOP THE BUST WHILE PROTECTING IT

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1500095A FR3031675B1 (en) 2015-01-19 2015-01-19 COSMETIC OR PHARMACEUTICAL TREATMENT PROCESS WITHOUT THERAPEUTIC AIMS INTENDED TO DEVELOP THE BUST WHILE PROTECTING IT

Publications (2)

Publication Number Publication Date
FR3031675A1 FR3031675A1 (en) 2016-07-22
FR3031675B1 true FR3031675B1 (en) 2021-11-26

Family

ID=53059215

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1500095A Expired - Fee Related FR3031675B1 (en) 2015-01-19 2015-01-19 COSMETIC OR PHARMACEUTICAL TREATMENT PROCESS WITHOUT THERAPEUTIC AIMS INTENDED TO DEVELOP THE BUST WHILE PROTECTING IT

Country Status (1)

Country Link
FR (1) FR3031675B1 (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3782159D1 (en) * 1987-03-10 1992-11-12 Sonnleithner Michael ORGANIC COMPOUNDS FOR ENLARGING THE FEMALE BREAST.
FR2937545B1 (en) * 2008-10-28 2011-01-07 Etienne Soudant COSMETIC AND PHARMACEUTICAL TREATMENT METHOD FOR REDUCING BOTH ENDOGENOUS SYNTHESIS OF SIRTUINE AND REDUCING MUSCULAR CONTRACTIONS AND COMPOSITIONS FOR ITS IMPLEMENTATION
FR2942721B1 (en) * 2009-03-09 2013-02-01 Peaux Cibles COSMETIC AND PHARMACEUTICAL TREATMENT PROCESS FOR REDUCING BOTH WRINKLES AND INCREASING FERMINE WITHOUT LIPOLYSIS AND COMPOSITIONS FOR IMPLEMENTING THE SAME

Also Published As

Publication number Publication date
FR3031675A1 (en) 2016-07-22

Similar Documents

Publication Publication Date Title
UA122479C2 (en) Antibody molecules to pd-1 and uses thereof
MX378579B (en) USE OF PRIDOPIDINE TO IMPROVE COGNITIVE FUNCTION AND FOR THE TREATMENT OF ALZHEIMER'S DISEASE.
GEP20217328B (en) Bispecific molecules having immunoreactivity with pd-1 and ctla-4, and methods of use thereof
EA201790802A1 (en) CONNECTIONS AGAINST TNF
MA67580B1 (en) OLIGONUCLEOTIDES TO INDUCE EXPRESSION OF PATERNAL UBE3A
BR112017025255A2 (en) stimulating and inhibiting methods, product, computer program product, system, and pharmaceutical compositions for use in the treatment or prevention of prostate cancer
SA518400552B1 (en) Phosphoramidate compounds
EP3429605A4 (en) THERAPEUTIC AGENT FOR THE TREATMENT OF DISEASES, IN PARTICULAR DISEASES AFFECTING THE CENTRAL NERVOUS SYSTEM
PH12018500578A1 (en) Methods of treating inflammatory diseases
FR3032353B1 (en) PHARMACEUTICAL COMPOSITION AND DEVICE FOR THE TREATMENT OF PAIN
BR112018011607A2 (en) compound, pharmaceutical composition, methods for treating an estrogen-related disorder and cancer, for manufacturing a medicament for therapeutic use in the treatment of a disorder, and for preventing an estrogen-related disorder, use of a compound or composition and process for preparing a pharmaceutical product.
UA119458C2 (en) Pladienolide pyridine compounds and methods of use
PH12017500944B1 (en) New 2` and/or 5` amino-acid ester phosphoramidate 3`-deoxy adenosine derivatives as anti-cancer compounds
EP3318267A4 (en) THERAPEUTIC AGENT AND METHOD FOR TREATING HUNTER'S DISEASE
BR112017025698A2 (en) compositions and methods for inhibiting hif2alpha gene expression
MA42657A (en) ANTI-PCSK9 ANTIBODY INHIBITORS FOR THE TREATMENT OF PATIENTS WITH HYPERLIPIDEMIA SUBJECTING LIPOPROTEIN APHERESIS
EP3238745A4 (en) CELL DEATH INDUCING AGENT, CYTOSTATIC AGENT, AND PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF DISEASES CAUSED BY ABNORMAL CELL GROWTH
MY174991A (en) Eurycoma longifolia extract and its use in enhancing and/or stimulating immune system
MX379359B (en) DERIVATIVES OF 8-AMINO-2-OXO-1,3-DIAZA-SPIRO-[4.5]-DECane.
EP3326638A4 (en) PHARMACEUTICAL COMPOSITION FOR THE PREVENTION OR TREATMENT OF IL-6 MEDIATED DISEASES COMPRISING FLOWER EXTRACT DEROSA RUGOSA
MX395492B (en) THERAPEUTIC USES OF L-4 CHLOROKYNURENINE.
EP3524690A4 (en) METHOD FOR PREDICTING THE EFFECTIVENESS OF CHEMOTHERAPY IN PATIENTS WITH BREAST CANCER
MX2018004041A (en) Treatment of bile acid disorders.
PH12015502351A1 (en) Herbal compositions for treating pain and skin disorders
EP3329910A4 (en) PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING ONYCHOMYCOSIS AND PREPARATION METHOD THEREOF

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

PLSC Publication of the preliminary search report

Effective date: 20160722

PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 6

PLFP Fee payment

Year of fee payment: 7

PLFP Fee payment

Year of fee payment: 8

PLFP Fee payment

Year of fee payment: 9

PLFP Fee payment

Year of fee payment: 10

ST Notification of lapse

Effective date: 20250905